Neurobiological Mechanisms of Nicotine Reward and Aversion
Open accessThe DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Abstract
5 nAChR subunits are also expressed. These aversion-related brain sites regulate nicotine avoidance behaviors, and genetic variation that modifies the function of nAChRs in these sites increases vulnerability to tobacco dependence and smoking-related diseases. Here, we review the molecular, cellular, and circuit-level mechanisms through which nicotine elicits reward and aversion and the adaptations in these processes that drive the development of nicotine dependence. SIGNIFICANCE STATEMENT: Tobacco use disorder in the form of habitual cigarette smoking or regular use of other tobacco-related products is a major cause of death and disease worldwide. This article reviews the actions of nicotine in the brain that contribute to tobacco use disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386 · cited 1×
“Tobacco smoking results in more than 5 million deaths each year worldwide (WHO, 2008), and it is predicted that approximately 0.6 billion current smokers will die from smoking-related illnesses (Ezzati and Lopez, 2003; Doll et al., 2004; Coe et al., 2005; Mathers and Loncar, 2006).”
BackgroundInfluentialThe MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932 · cited 1×
“Smokers who quit before the onset of tobacco-related illness can largely avoid the increased mortality risk (Doll et al., 1994; Peto et al., 2000).”
BackgroundActual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 2×
“6 billion current smokers will die from smoking-related illnesses (Ezzati and Lopez, 2003; Doll et al., 2004; Coe et al., 2005; Mathers and Loncar, 2006).”
BackgroundInfluentialDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Reitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028
Öberg, M., Jaakkola, M. S., Woodward, A., Peruga, A., & Prüss-Ustün, A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61388-8 · Cited by 1,939 · cited 1×
“Even in nonsmokers tobacco can be deadly, with over 880,000 people worldwide estimated to die annually year from diseases related to secondhand smoke exposure (Oberg et al., 2011).”
BackgroundMammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523 · cited 1×
“Allelic variation in CHRNA5, the gene that encodes the a5 nAChR subunit, is heavily associated with vulnerability to nicotine dependence (Berrettini et al., 2008; Bierut et al., 2008; Hung et al., 2008; Thorgeirsson et al., 2008).”
BackgroundPicciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · cited 2×
“nAChRs in the CNS are located primarily on presynaptic terminals (Wonnacott, 1997) but can also be found at somatodendritic and postsynaptic locations (Clarke et al. 1986; Sargent, 1993).”
BackgroundInput-specific control of reward and aversion in the ventral tegmental area
Lammel, S., Lim, B. K., Ran, C., Huang, K. W., Betley, M. J., Tye, K. M., Deisseroth, K., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11527 · Cited by 1,300
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275 · cited 1×
“Allelic variation in CHRNA5, the gene that encodes the a5 nAChR subunit, is heavily associated with vulnerability to nicotine dependence (Berrettini et al., 2008; Bierut et al., 2008; Hung et al., 2008; Thorgeirsson et al., 2008).”
BackgroundEstimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247 · cited 2×
“6 billion current smokers will die from smoking-related illnesses (Ezzati and Lopez, 2003; Doll et al., 2004; Coe et al., 2005; Mathers and Loncar, 2006).”
BackgroundInfluentialDamage to the insula disrupts addiction to cigarette smoking
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007) · Science · doi:10.1126/science.1135926 · Cited by 1,245
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · cited 2×
“…of the IPn (Qin and Luo, 2009). nAChRs located on the presynaptic terminals of mHb inputs to the IPn regulate neurotransmitter release into the IPn, and the mHb-IPn synapse has long served as a model system for nAChR signaling in the brain (Sastry, 1978; Brown et al., 1983; McGehee et al., 1995).”
MethodPharmacology of nicotine: addiction, smoking-induced disease, and therapeutics
Benowitz, N. L. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094742 · Cited by 979 · cited 1×
“Despite awareness of the dangers of smoking, approximately 80% of current smokers attempting to quit will relapse within the first month of abstinence (Benowitz, 2009).”
BackgroundUnique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system
Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., & Roeper, J. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.022 · Cited by 976
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930 · cited 4×
“Tobacco smoking results in more than 5 million deaths each year worldwide (WHO, 2008), and it is predicted that approximately 0.6 billion current smokers will die from smoking-related illnesses (Ezzati and Lopez, 2003; Doll et al., 2004; Coe et al., 2005; Mathers and Loncar, 2006).”
BackgroundInfluentialBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl438 · Cited by 850
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli
Lammel, S., Ion, D. I., Roeper, J., & Malenka, R. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.025 · Cited by 766 · cited 2×
“The fact that VTA dopamine neurons regulate both the rewarding and aversive properties of nicotine reflects the remarkable functional heterogeneity of these cells, with discrete populations likely specializing in positive or negative reinforcement processes (Lammel et al., 2011, 2012, 2014).”
BackgroundLong-term potentiation of excitatory inputs to brain reward areas by nicotine
Mansvelder, H. D., & McGehee, D. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00042-8 · Cited by 720
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701 · cited 1×
“In parallel, nicotine activates then rapidly desensitizes b2* nAChRs expressed by VTA GABAergic neurons (Mansvelder et al., 2002; Yang et al., 2011).”
BackgroundJhou, T. C., Fields, H. L., Baxter, M. G., Saper, C. B., & Holland, P. C. (2009) · Neuron · doi:10.1016/j.neuron.2009.02.001 · Cited by 696
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693
Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior
The ENGAGE Consortium, Thorgeirsson, T. E., Gudbjartsson, D. F., Surakka, I., Vink, J. M., Amin, N., Geller, F., Sulem, P., Rafnar, T., Esko, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.573 · Cited by 689 · cited 3×
“Indeed, optical stimulation of cholinergic interneurons in the striatum was shown to increase dopamine release in an impulse-independent manner through a direct action of acetylcholine at b2* nAChRs located on the terminals of dopamine neurons (Cachope et al., 2012; Threlfell et al., 2012).”
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663
Self-citationVariants in Nicotinic Receptors and Risk for Nicotine Dependence
Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., Saccone, N. L., Saccone, S. F., Bertelsen, S., Fox, L., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111711 · Cited by 648
Acetylcholine Receptor: An Allosteric Protein
Changeux, J.-P., Devillers-Thiéry, A., & Chemouilli, P. (1984) · Science · doi:10.1126/science.6382611 · Cited by 623
Novel genes identified in a high-density genome wide association study for nicotine dependence
Bierut, L. J., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F., Swan, G. E., Rutter, J., Bertelsen, S., Fox, L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl441 · Cited by 622
Santoro, B., Chen, S., Lüthi, A., Pavlidis, P., Shumyatsky, G. P., Tibbs, G. R., & Siegelbaum, S. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05264.2000 · Cited by 600 · cited 2×
“, 2013), which likely reflects “pacemaker” activity driven by the high concentrations of HCN4 channels expressed by these cells (Monteggia et al., 2000; Santoro et al., 2000; Gorlich et al., 2013; Oyrer et al., 2019).”
BackgroundThe insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making
Naqvi, N. H., & Bechara, A. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0268-7 · Cited by 598
Nicotine amplifies reward-related dopamine signals in striatum
Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594 · cited 8×
“Nicotine appeared to act in this manner by blocking short-term inhibitory plasticity in dopamine neurons (Rice and Cragg, 2004), which serves to limit dopamine release during periods of high activity (Cragg, 2003), and instead enhancing short-term calcium-dependent excitatory plasticity (Zhang and…”
BackgroundMethodInfluentialEndogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585 · cited 25×
“NAc core dopamine lesions also attenuated conditioned taste avoidance triggered by intravenous nicotine infusions (Sellings et al., 2008).”
BackgroundInfluentialNicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 3×
“Chrnb2 re-expression in the VTA also restored the reinforcing and locomotor-stimulating properties of nicotine in b2 knockout mice (Maskos et al., 2005).”
BackgroundVarenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533 · cited 1×
“Varenicline dose-dependently decreased nicotine self-administration in rats (Rollema et al., 2007; O’Connor et al., 2010), with this action thought to directly reflect the ability of varenicline to attenuate the stimulatory actions of nicotine on VTA dopamine neurons (Harmey et al., 2012).”
BackgroundJhou, T. C., Geisler, S., Marinelli, M., Degarmo, B. A., & Zahm, D. S. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21891 · Cited by 503 · cited 2×
“In turn, RMTg GABA neurons project to the VTA where they can inhibit dopamine neurons to elicit aversion-related behaviors (Jhou et al., 2009a,b; Hong et al., 2011; Barrot et al., 2012).”
BackgroundGöke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 1×
“Some of the highest densities of GLP-1 receptor binding sites in the brain are detected in the IPn (Goke et al., 1995), suggesting that GLP-1–expressing nTS neurons project to the IPn and thereby regulate nicotine intake.”
BackgroundStructural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking
Berrettini, W., Yuan, X., Tozzi, F., Song, K., Francks, C., Chilcoat, H., Waterworth, D., Muglia, P., & Mooser, V (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002154 · Cited by 465
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464
The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats
Clarke, P. B. S., & Kumar, R. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb09398.x · Cited by 457
Symptoms of Tobacco Withdrawal: A Replication and Extension
Hughes, J. R. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250054007 · Cited by 449
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422 · cited 1×
“B. b2* nAChR Subtypes and Nicotine Reward a4b2* nAChRs are the most abundant subtype in the mammalian CNS (Flores et al., 1992). a4b2 nAChRs occur in two discrete stoichiometries: (a4b2)2b2 or (a4b2)2a4 subtypes (Nelson et al., 2003; Gotti et al., 2009).”
BackgroundLe Novère, N., Corringer, P., & Changeux, J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10153 · Cited by 411
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407 · cited 5×
“…ligand-binding, genetic deletion, and targeted lesion studies support the existence of at least four species of nAChRs on the terminals of VTA dopamine neurons in striatum: (a4b2)2(a4), (a4b2)2(a5), (a4b2)(a6b2)b3, (a6b2)2b2, and (a6b2)2b3 (Zoli et al., 2002; Salminen et al., 2004) (Fig.”
BackgroundResultInfluentialNicotinic effects on the firing pattern of midbrain dopamine neurons
GRENHOFF, J., ASTON‐JONES, G., & SVENSSON, T. H. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07988.x · Cited by 399 · cited 2×
“This action is thought to reflect the ability of nicotine to stimulate VTA dopamine neurons (Pidoplichko et al., 1997) and increase their burst patterns of firing (Grenhoff et al., 1986; De Biasi and Dani, 2011).”
BackgroundEffect of smoking history on [3H]nicotine binding in human postmortem brain
Breese, C. R., Marks, M. J., Logel, J., Adams, C. E., Sullivan, B., Collins, A. C., & Leonard, S. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36798-9 · Cited by 396
Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey
Schultz, W. (1986) · Journal of Neurophysiology · doi:10.1152/jn.1986.56.5.1439 · Cited by 390 · cited 2×
“However, when dopamine release was stimulated using multiple pulses in a manner that recapitulates burst-like firing patterns (usually 15–100Hz) thought to occur when rewarding or rewardpredictive stimuli are encountered (Schultz, 1986), nicotine instead increased dopamine release (Rice and Cragg, 2004; Zhang and Sulz…”
BackgroundMethodHong, S., Jhou, T. C., Smith, M., Saleem, K. S., & Hikosaka, O. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1384-11.2011 · Cited by 390
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · cited 1×
“This action is thought to reflect the ability of nicotine to stimulate VTA dopamine neurons (Pidoplichko et al., 1997) and increase their burst patterns of firing (Grenhoff et al., 1986; De Biasi and Dani, 2011).”
BackgroundStamatakis, A. M., Jennings, J. H., Ung, R. L., Blair, G. A., Weinberg, R. J., Neve, R. L., Boyce, F., Mattis, J., Ramakrishnan, C., Deisseroth, K., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.08.023 · Cited by 364 · cited 2×
“VTA-derived glutamate transmission in the LHb regulates aversion-related behaviors (Root et al., 2014a), whereas VTA-derived GABA transmission in the LHb regulates rewardrelated behaviors (Stamatakis et al., 2013).”
BackgroundFrequency-dependent modulation of dopamine release by nicotine
Zhang, H., & Sulzer, D. (2004) · Nature Neuroscience · doi:10.1038/nn1243 · Cited by 361 · cited 6×
“…was stimulated using multiple pulses in a manner that recapitulates burst-like firing patterns (usually 15–100Hz) thought to occur when rewarding or rewardpredictive stimuli are encountered (Schultz, 1986), nicotine instead increased dopamine release (Rice and Cragg, 2004; Zhang and Sulzer, 2004).”
BackgroundMethodInfluentialDesensitization of nicotinic ACh receptors: shaping cholinergic signaling
GINIATULLIN, R., NISTRI, A., & YAKEL, J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.04.009 · Cited by 357 · cited 1×
“…the mHb of the TCF7L2 mutant rats resulted in striking deficits in the production of cAMP in mHb neurons, which reduced activity of the cAMP-regulated protein kinases that positively regulate nAChR function in mHb neurons (Huganir et al., 1986; Paradiso and Brehm, 1998; Giniatullin et al., 2005).”
BackgroundSingle rodent mesohabenular axons release glutamate and GABA
Root, D. H., Mejias-Aponte, C. A., Zhang, S., Wang, H.-L., Hoffman, A. F., Lupica, C. R., & Morales, M. (2014) · Nature Neuroscience · doi:10.1038/nn.3823 · Cited by 349
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · cited 2×
“…withdrawal from nicotine, accomplished by the surgical removal of subcutaneously implanted osmotic minipumps that delivered nicotine continuously for >7 days, was associated with the expression of a physical withdrawal syndrome in rats (Malin et al., 1992; Epping-Jordan et al., 1998).”
BackgroundClarke, P. B., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22152-8 · Cited by 318
Ren, J., Qin, C., Hu, F., Tan, J., Qiu, L., Zhao, S., Feng, G., & Luo, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.038 · Cited by 315 · cited 1×
“IPn neurons that receive excitatory inputs from the mHb are perhaps the most nicotine-responsive cells in the brain, as measured by nicotineinduced cFos immunoreactivity (Ren and Sagar, 1992; Pang et al., 1993; Salminen et al., 2000).”
BackgroundEffects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
van Bloemendaal, L., ten Kulve, J. S., la Fleur, S. E., Ijzerman, R. G., & Diamant, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0414 · Cited by 312 · cited 1×
“GLP-1 neurons are known to be activated by gastric expansion to induce feelings of satiety and trigger cessation of food consumption (van Bloemendaal et al., 2014).”
BackgroundPons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M., Changeux, J. P., Maskos, U., & Fratta, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3918-08.2008 · Cited by 312
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · cited 6×
“Nicotine has both positive and negative reinforcing properties, meaning that the drug enhances the activity of brain reward circuits (positive reinforcement) while attenuating the activity of brain aversion circuits during withdrawal (negative reinforcement) (Kenny and Markou, 2001).”
BackgroundInfluentialSelf-citationSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · cited 4×
“The role for a2 nAChRs in nicotine withdrawal is complex, however, as one study reported that physical withdrawal signs were attenuated in a2 nAChR subunit knockout mice (Salas et al., 2009), and another reported that physical withdrawal was exacerbated in these animals (Lotfipour et al., 2013).”
BackgroundResultInfluentialHierarchical Control of Dopamine Neuron-Firing Patterns by Nicotinic Receptors
Mameli-Engvall, M., Evrard, A., Pons, S., Maskos, U., Svensson, T. H., Changeux, J.-P., & Faure, P. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.007 · Cited by 296
Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284
Frahm, S., Ślimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer, S., Filkin, S., Pons, S., Fontaine, J.-F., Tsetlin, V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.013 · Cited by 283
Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2199-07.2007 · Cited by 274 · cited 3×
“Nicotine-induced upregulation of nAChR expression has been detected in the brains of rodents and human smokers (Marks et al., 1983; Breese et al., 1997; Staley et al., 2006; Nashmi et al., 2007).”
BackgroundWeiss, R. B., Baker, T. B., Cannon, D. S., von Niederhausern, A., Dunn, D. M., Matsunami, N., Singh, N. A., Baird, L., Coon, H., McMahon, W. M., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000125 · Cited by 271 · cited 2×
“Alleles in CHRNA5 are also associated with heavy smoking (Berrettini et al., 2008; Bierut et al., 2008; Grucza et al., 2008; Stevens et al., 2008), early onset of smoking behavior (Weiss et al., 2008), and with “pleasurable buzz” from tobacco (Sherva et al., 2008).”
BackgroundForster, G. L., & Blaha, C. D. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00250.x · Cited by 271
Smoking withdrawal dynamics in unaided quitters.
Piasecki, T. M., Niaura, R., Shadel, W. G., Abrams, D., Goldstein, M., Fiore, M. C., & Baker, T. B. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.1.74 · Cited by 262 · cited 1×
“The duration and severity of the nicotine withdrawal syndrome in abstinent smokers accurately predict their likelihood of relapse to tobacco use (Piasecki et al., 1998, 2000, 2003).”
BackgroundKenny, P. J., & Markou, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300905 · Cited by 261
Self-citationThe subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252 · cited 4×
“Indeed, the (a4b2)(a6b2)b3 nAChR subtype has the highest sensitivity to nicotine of any native nAChR so far identified (Grady et al., 2007).”
BackgroundInfluentialExley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242 · cited 1×
“…effects of nicotine on dopamine release in the striatum (Cui et al., 2003; Salminen et al., 2004, 2007; Grady et al., 2007, 2010), with a4b2* and (non-a4)(a6b2)2* nAChRs located on the terminals of dopamine neurons regulating the actions of nicotine in the striatum (Exley et al., 2008, 2011) (Fig.”
BackgroundMarubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242
Shumake, J., Edwards, E., & Gonzalez-Lima, F. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04048-9 · Cited by 232 · cited 1×
“The mHb-IPn circuit may also coordinate adaptive physiologic and behavioral responses to stressful or anxiety-provoking stimuli (Lisoprawski et al., 1981; Murray et al., 1994; Shumake et al., 2003; Hsu et al., 2012, 2016; Xu et al., 2018; Duncan et al., 2019; Sherafat et al., 2020).”
BackgroundStaley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 229 · cited 2×
“Nicotine-induced upregulation of nAChR expression has been detected in the brains of rodents and human smokers (Marks et al., 1983; Breese et al., 1997; Staley et al., 2006; Nashmi et al., 2007).”
BackgroundGotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5095-09.2010 · Cited by 226
Grady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · cited 2×
“Similarly, systemic administration of chlorisondamine at doses unlikely to cross the blood-brain barrier or its direct intracerebroventricular administration also elevated ICSS thresholds in nicotine-dependent rats (Epping-Jordan et al., 1998; Watkins et al., 2000).”
BackgroundCui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213
Walters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206 · cited 2×
“Similar to b2 nAChR subunit knockout mice (Walters et al., 2006), deletion of a4 nAChR subunits in the ventral midbrain blocked nicotine-induced CPP in mice (Peng et al., 2017).”
GLP-1 acts on habenular avoidance circuits to control nicotine intake
Tuesta, L. M., Chen, Z., Duncan, A., Fowler, C. D., Ishikawa, M., Lee, B. R., Liu, X.-A., Lu, Q., Cameron, M., Hayes, M. R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4540 · Cited by 200
Self-citationHildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200
Urges to smoke during the first month of abstinence: relationship to relapse and predictors
Doherty, K., Kinnunen, T., Militello, F. S., & Garvey, A. J. (1995) · Psychopharmacology · doi:10.1007/bf02246158 · Cited by 198
Roles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · cited 6×
“However, in the brain a5 subunits preferentially assemble into a4b2* nAChR subtypes and are rarely detected in a3* nAChRs (Gotti et al., 2007; Perry et al., 2007; Kuryatov et al., 2008; Mechanisms of Tobacco Use Disorder 289 Mao et al., 2008).”
BackgroundInfluentialNicotinic Receptor Gene Variants Influence Susceptibility to Heavy Smoking
Stevens, V. L., Bierut, L. J., Talbot, J. T., Wang, J. C., Sun, J., Hinrichs, A. L., Thun, M. J., Goate, A., & Calle, E. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0585 · Cited by 190
Piasecki, T. M., Fiore, M. C., & Baker, T. B. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.2.238 · Cited by 189
Interoceptive basis to craving
Gray, M. A., & Critchley, H. D. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.024 · Cited by 189
Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28721 · Cited by 187
Kuryatov, A., Berrettini, W., & Lindstrom, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.066357 · Cited by 171 · cited 1×
“In Xenopus oocytes, only the function of a4b2a5* nAChRs but not a3b4a5* or a3b2a5* nAChRs was affected by incorporation of mutant a5 subunits modified to include the major smoking-related CHRNA5 risk allele (D398N), as measured by agonist-evoked calcium influx (Kuryatov et al., 2011).”
BackgroundMcGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165
Rollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00682.x · Cited by 162 · cited 1×
“These compounds have shown clinical utility as smoking cessation medications in humans (Barlow and McLeod, 1969; Reavill et al., 1990; Etter, 2006; Rollema et al., 2010).”
BackgroundSmoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations
Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.1.14 · Cited by 159
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159 · cited 7×
“…in dorsal striatum, likely to compensate for deficits in the function of (a4b2)2a5* nAChRs thought to specialize in regulating dopamine transmission in dorsal striatum (Champtiaux et al., 2002, 2003; Marubio et al., 2003; Salminen et al., 2004; Grady et al., 2010; Exley et al., 2011, 2012) (Fig.”
BackgroundMethodResultInfluentialGrady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156 · cited 1×
“Intriguingly, a3b4* nAChRs are thought to exclusively regulate acetylcholine release in the mHb-IPn circuit (Grady et al., 2001; Hussain et al., 2008; Grady et al., 2009), whereas a4b2a5* nAChRs regulate glutamate transmission (Girod et al.”
BackgroundThe habenulo-interpeduncular pathway in nicotine aversion and withdrawal
Antolin-Fontes, B., Ables, J. L., Görlich, A., & Ibañez-Tallon, I. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.019 · Cited by 154 · cited 1×
“…tract (nTS) (Marks et al., 1992; WinzerSerhan and Leslie, 1997; Sheffield et al., 2000; De Biasi and Salas, 2008; O’Leary et al., 2008; Grady et al., 2009; Frahm et al., 2011; Tuesta et al., 2011, 2017; Hsu et al., 2013; Antolin-Fontes et al., 2015; Morton et al., 2018; Husson et al., 2020).”
BackgroundSelf-citationA Risk Allele for Nicotine Dependence in CHRNA5 Is a Protective Allele for Cocaine Dependence
Grucza, R. A., Wang, J. C., Stitzel, J. A., Hinrichs, A. L., Saccone, S. F., Saccone, N. L., Bucholz, K. K., Cloninger, C. R., Neuman, R. J., Budde, J. P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.018 · Cited by 152
Ikemoto, S., Qin, M., & Liu, Z.-H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4542-05.2006 · Cited by 151 · cited 8×
“Consistent with both possibilities, nicotine is self-administered only into posterior but not anterior regions of VTA by rats (Ikemoto et al., 2006), and nicotine modulates the balance between excitatory and inhibitory drive onto VTA dopamine neurons in a manner that depends on their precise…”
BackgroundInfluentialCo-activation of VTA DA and GABA neurons mediates nicotine reinforcement
Tolu, S., Eddine, R., Marti, F., David, V, Graupner, M., Pons, S., Baudonnat, M., Husson, M., Besson, M., Reperant, C., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.83 · Cited by 151
Lips, E. H., Gaborieau, V., McKay, J. D., Chabrier, A., Hung, R. J., Boffetta, P., Hashibe, M., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., et al. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp288 · Cited by 145
Sherva, R., Wilhelmsen, K., Pomerleau, C. S., Chasse, S. A., Rice, J. P., Snedecor, S. M., Bierut, L. J., Neuman, R. J., & Pomerleau, O. F. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02279.x · Cited by 143
Maskos, U. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.5 · Cited by 139
Zangen, A., Ikemoto, S., Zadina, J. E., & Wise, R. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07225.2002 · Cited by 138 · cited 1×
“Similarly, ethanol, cocaine, opioids, and cholinergic agonists are all volitionally self-administered into the pVTA but are not reliably self-administered into the aVTA (Rodd-Henricks et al., 2000; Ikemoto and Wise, 2002; Zangen et al., 2002; David et al., 2004; Rodd et al., 2005).”
BackgroundShih, P.-Y., Engle, S. E., Oh, G., Deshpande, P., Puskar, N. L., Lester, H. A., & Drenan, R. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0476-14.2014 · Cited by 136 · cited 5×
“to rostral and dorsomedial domains of the IPn (Mulle et al., 1991; Shih et al., 2014).”
BackgroundInfluentialThe Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155457 · Cited by 135
Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · cited 2×
“…reward thresholds, the induction of a conditioned place avoidance (CPA), decrements in sucrose consumption, increases in anxiety-related behaviors, and other behavioral abnormalities consistent with the manifestation of a negative affective state (see Kenny and Markou, 2001; Fowler et al., 2008).”
BackgroundSelf-citationZhao-Shea, R., Liu, L., Pang, X., Gardner, P. D., & Tapper, A. R. (2013) · Current Biology · doi:10.1016/j.cub.2013.09.041 · Cited by 129 · cited 6×
“The onset of nicotine withdrawal was associated with increased activity of IPn GABAergic neurons, as reflected by increased cFos expression and spontaneous excitatory currents in IPn neurons (Zhao-Shea et al., 2013).”
BackgroundInfluentialDrenan, R. M., Grady, S. R., Steele, A. D., McKinney, S., Patzlaff, N. E., McIntosh, J. M., Marks, M. J., Miwa, J. M., & Lester, H. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2056-10.2010 · Cited by 127
Nicotine consumption is regulated by a human polymorphism in dopamine neurons
Morel, C., Fattore, L., Pons, S., Hay, Y. A., Marti, F., Lambolez, B., De Biasi, M., Lathrop, M., Fratta, W., Maskos, U., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.158 · Cited by 123 · cited 2×
“The direct stimulatory effects of nicotine on VTA dopamine neurons are attenuated in a5 subunit knockout mice (Morel et al., 2014; Sciaccaluga et al., 2015) consistent with the attenuated striatal dopamine responses to nicotine in these mice.”
BackgroundFacilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors
Girod, R., Barazangi, N., McGehee, D., & Role, L. W. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00145-3 · Cited by 122 · cited 3×
“, 2009), whereas a4b2a5* nAChRs regulate glutamate transmission (Girod et al., 2000).”
BackgroundHildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997) · Psychopharmacology · doi:10.1007/s002130050200 · Cited by 122
Ouagazzal, A.-M., Kenny, P. J., & File, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050976 · Cited by 121 · cited 1×
“…on VTA dopamine neurons that project to the IPn, potentially through a5* nAChRs expressed by these cells, may contribute to its well known anxiety-promoting actions and other aversive responses that promote nicotine avoidance (File et al., 1998, 2000; Ouagazzal et al., 1999a,b; Kenny et al., 2000).”
BackgroundSelf-citationHabenular TCF7L2 links nicotine addiction to diabetes
Duncan, A., Heyer, M. P., Ishikawa, M., Caligiuri, S. P. B., Liu, X.-A., Chen, Z., Micioni Di Bonaventura, M. V., Elayouby, K. S., Ables, J. L., Howe, W. M., et al. (2019) · Nature · doi:10.1038/s41586-019-1653-x · Cited by 119
Self-citationSensory blockade of smoking satisfaction
Rose, J. E., Tashkin, D. P., Ertle, A., Zinser, M. C., & Lafer, R. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90572-6 · Cited by 117 · cited 1×
“Moreover, blocking the sensory properties of nicotine in cigarette smokers attenuates the rewarding properties of cigarettes and decreases smoking behavior (Rose et al., 1985, 1993, 2016; McClernon et al., 2016).”
BackgroundSalas, R., Cook, K. D., Bassetto, L., & De Biasi, M. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.05.002 · Cited by 115 · cited 3×
“Indeed, b4 nAChR subunit knockout mice had decreased physical signs in response to spontaneous or mecamylamine-precipitated nicotine withdrawal (Salas et al., 2004b; Stoker et al., 2012).”
BackgroundLaviolette, S. R., & van der Kooy, D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1317-6 · Cited by 113
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106 · cited 5×
“However, in the brain a5 subunits preferentially assemble into a4b2* nAChR subtypes and are rarely detected in a3* nAChRs (Gotti et al., 2007; Perry et al., 2007; Kuryatov et al., 2008; Mechanisms of Tobacco Use Disorder 289 Mao et al., 2008).”
BackgroundInfluentialSpina, L., Fenu, S., Longoni, R., Rivas, E., & Di Chiara, G. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0211-4 · Cited by 102 · cited 1×
“Blockade of dopamine receptors also reduced nicotine self-administration in rats (Corrigall and Coen, 1991; Corrigall et al., 1992) and attenuated nicotine-induced conditioned place preference (CPP) (Acquas et al., 1989; Spina et al., 2006).”
BackgroundDrenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100
An essential role of acetylcholine-glutamate synergy at habenular synapses in nicotine dependence
Frahm, S., Antolin-Fontes, B., Görlich, A., Zander, J.-F., Ahnert-Hilger, G., & Ibañez-Tallon, I. (2015) · eLife · doi:10.7554/elife.11396 · Cited by 98
Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96 · cited 2×
“…tegmental area (VTA) and nucleus accumbens (NAc), which have been heavily implicated in nicotine reinforcement processes (Schwartz et al., 1984; Carboni et al., 2000b; Mansvelder and McGehee, 2000; Fu et al., 2003). nAChRs are expressed by midbrain dopamine neurons (Clarke and Pert, 1985), and…”
BackgroundBrunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.171 · Cited by 95 · cited 1×
“…rodents abolished the stimulatory effects of nicotine on dopamine transmission in the striatum and decreased nicotine self-administration behavior (Brunzell et al., 2010; Gotti et al., 2010; Brunzell, 2012; Sanjakdar et al., 2015), with the a6b2* nAChR subtype hypothesized to play a prominent…”
BackgroundInfluence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi, M., & Salas, R. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-mr-355 · Cited by 95 · cited 2×
“…nucleus (IPn), and nucleus of the solitary tract (nTS) (Marks et al., 1992; WinzerSerhan and Leslie, 1997; Sheffield et al., 2000; De Biasi and Salas, 2008; O’Leary et al., 2008; Grady et al., 2009; Frahm et al., 2011; Tuesta et al., 2011, 2017; Hsu et al., 2013; Antolin-Fontes et…”
BackgroundSartor, C. E., Lessov-Schlaggar, C. N., Scherrer, J. F., Bucholz, K. K., Madden, P. A. F., Pergadia, M. L., Grant, J. D., Jacob, T., & Xian, H. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.03.004 · Cited by 93 · cited 2×
“Sensiti-vity to nicotine aversion is thought to influence the likelihood of transitioning from occasional to regular tobacco use (Sartor et al., 2010; Fowler and Kenny, 2014).”
BackgroundDavid, V., Besson, M., Changeux, J.-P., Granon, S., & Cazala, P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.02.003 · Cited by 87 · cited 1×
“Similarly, ethanol, cocaine, opioids, and cholinergic agonists are all volitionally self-administered into the pVTA but are not reliably self-administered into the aVTA (Rodd-Henricks et al., 2000; Ikemoto and Wise, 2002; Zangen et al., 2002; David et al., 2004; Rodd et al., 2005).”
BackgroundDeficits in a sustained attention task following nicotine withdrawal in rats
Shoaib, M., & Bizarro, L. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2004-6 · Cited by 87
Sheffield, E. B., Quick, M. W., & Lester, R. A. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00138-6 · Cited by 87
A CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans
Jensen, K. P., DeVito, E. E., Herman, A. I., Valentine, G. W., Gelernter, J., & Sofuoglu, M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.131 · Cited by 85 · cited 22×
“Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, et al. (2008) A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.”
BackgroundInfluentialNicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum
Wolfman, S. L., Gill, D. F., Bogdanic, F., Long, K., Al-Hasani, R., McCall, J. G., Bruchas, M. R., & McGehee, D. S. (2018) · Nature Communications · doi:10.1038/s41467-018-04654-2 · Cited by 81
Salas, R., Main, A., Gangitano, D., & De Biasi, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.017 · Cited by 76
Besson, M., David, V., Suarez, S., Cormier, A., Cazala, P., Changeux, J.-P., & Granon, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0418-z · Cited by 73
Rodd, Z. A., Bell, R. L., Kuc, K. A., Zhang, Y., Murphy, J. M., & McBride, W. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075952 · Cited by 72 · cited 1×
“Similarly, ethanol, cocaine, opioids, and cholinergic agonists are all volitionally self-administered into the pVTA but are not reliably self-administered into the aVTA (Rodd-Henricks et al., 2000; Ikemoto and Wise, 2002; Zangen et al., 2002; David et al., 2004; Rodd et al., 2005).”
BackgroundBordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70 · cited 2×
“a6b2* nAChRs are activated by cytisine and varenicline far more efficiently than other b2* nAChRs (Salminen et al., 2004; Bordia et al., 2012), suggesting that they may contribute to the clinical utility 278 Wills et al.”
BackgroundLotfipour, S., Byun, J. S., Leach, P., Fowler, C. D., Murphy, N. P., Kenny, P. J., Gould, T. J., & Boulter, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4731-12.2013 · Cited by 68 · cited 4×
“a2 nAChR subunit knockout mice show higher levels of intravenous nicotine self-administration during the acquisition phase when nicotine-taking behavior is being established but not after stable intake has been established (Lotfipour et al., 2013).”
BackgroundInfluentialSelf-citationPortugal, G. S., Kenney, J. W., & Gould, T. J. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.05.002 · Cited by 66 · cited 2×
“Deficits in context-related encoding of fear memories typically seen in mice experiencing nicotine withdrawal were unaltered in a7 knockout mice, whereas similar withdrawal-related cognitive deficits were absent in b2 subunit knockout mice (Portugal et al., 2008).”
BackgroundIyaniwura, T., Wright, A., & Balfour, D. (2001) · Psychopharmacology · doi:10.1007/s002130100852 · Cited by 57 · cited 1×
“Nicotine enhances dopamine transmission more robustly in the shell region of the NAc compared with the NAc core region (Nisell et al., 1997; Lecca et al., 2006), with the NAc shell thought to play an important role in nicotine reward (Iyaniwura et al., 2001; Sellings et al., 2008).”
BackgroundNicotine Enhances Excitability of Medial Habenular Neurons via Facilitation of Neurokinin Signaling
Dao, D. Q., Perez, E. E., Teng, Y., Dani, J. A., & De Biasi, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2736-13.2014 · Cited by 56
Raybuck, J. D., & Gould, T. J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06580.x · Cited by 53 · cited 1×
“Deficits in fear conditioning typically observed in wild-type mice experiencing nicotine withdrawal were also attenuated in b2 knockout mice (Portugal et al., 2008; Raybuck and Gould, 2009).”
BackgroundCigarette smoking: Effects upon self-rated stress and arousal over the day
Parrott, A. C. (1993) · Addictive Behaviors · doi:10.1016/0306-4603(93)90055-e · Cited by 53
Nicotine withdrawal in the rat: role of α7 nicotinic receptors in the ventral tegmental area
Nomikos, G. G., Hildebrand, B. E., Panagis, G., & Svensson, T. H. (1999) · Neuroreport · doi:10.1097/00001756-199903170-00007 · Cited by 45 · cited 2×
“Infusion of MLA into the VTA of nicotinedependent rats decreased accumbal dopamine release in a manner similar to mecamylamine infusion (Nomikos et al., 1999), suggesting that a7 nAChRs may contribute to deficits in dopamine transmission during nicotine withdrawal (Nomikos et al.”
BackgroundChronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry
Arvin, M. C., Jin, X.-T., Yan, Y., Wang, Y., Ramsey, M. D., Kim, V. J., Beckley, N. A., Henry, B. A., & Drenan, R. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2816-18.2019 · Cited by 42 · cited 2×
“the sensitivity of nAChRs in the mHb to nicotine (Pang et al., 2016; Arvin et al., 2019), with habenular a4* and a6* nAChRs located in the ventroinferior portion of the”
BackgroundStoker, A. K., Olivier, B., & Markou, A. (2012) · Behavior Genetics · doi:10.1007/s10519-011-9511-0 · Cited by 40
Reuben, M., Boye, S., & Clarke, P. B. S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00004-2 · Cited by 33 · cited 2×
“If a6* nAChRs only regulate the actions of nicotine in the striatum and not in the VTA, then nicotine may modulate dopamine release through dissociable actions on dopamine neurons at somatodendritic and terminal brain regions (Reuben et al., 2000).”
Background
Cited by
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Self-citationReynolds, L. M., Gulmez, A., Fayad, S. L., Campos, R. C., Rigoni, D., Nguyen, C., Le Borgne, T., Topilko, T., Rajot, D., Franco, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53327-w · Cited by 10
“While the effects of nicotine on DA neurons are best studied in adult animals 13 – 15 , some evidence does suggest that both the immediate and enduring effects of nicotine on ventral tegmental area (VTA) DA neurons differ between adolescent and adult administration 16,17 .”
BackgroundLakosa, A., Rahimian, A., Tomasi, F., Marti, F., Reynolds, L. M., Tochon, L., David, V., Danckaert, A., Canonne, C., Tahraoui, S., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01563-x · Cited by 10
“While the rewarding actions of nicotine are crucial in establishing smoking habits, nicotine’s aversive effects are thought to protect against transitioning to regular tobacco use [66, 69].”
Background
Metadata
- Authors
- Wills, L., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 74
- Issue
- 1
- Pages
- 271-310
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W4206666881
- Cited by
- 121
- References
- 159
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.